A real-world study of over 20,000 patients found that 17.7% of semaglutide users regained all the weight they had lost, or even exceeded their initial weight, within one year of stopping
First, PCOS was identified based on the presence of at least one diagnosis code, without requiring that it appear as a primary diagnosis or be confirmed across multiple encounters
So, I got to thinking about this a year ago very differently than the way it was being promoted at the time
Trials for Retatrutide use different designs, doses, and timeframes compared with older studies, so direct comparisons are not straightforward
This leads to increase in gastric volumes and putting the patients at increased risk of aspiration during sedation (107)
See how this triple-agonist outperforms Ozempic and Mounjaro